InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Explore the complete record of transactions filed by Bachleda Mark. Director active across 1 company, notably Galera Therapeutics, Inc.. In total, 1 filings have been published. Split: 1 buy · 0 sell. Total volume traded: €23k. History available since 16 March 2023. The latest transaction was filed on 16 March 2023 (Acquisition). Regulator: SEC (Form 4). The full history is free.
1 of 1 declaration